New Antiviral on the Horizon for Mild to Moderate COVID-19

JAMA. 2024 Mar 12;331(10):821. doi: 10.1001/jama.2024.0729.
No abstract available

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment* / trends
  • COVID-19* / therapy
  • Humans
  • SARS-CoV-2

Substances

  • Antiviral Agents